Bone Marrow Transplant Facility Coming to Austin

Austin is finally getting its first bone marrow transplant center.

Thanks to a collaboration between St. David's HealthCare, the Texas Transplant Institute at Methodist Hospital in San Antonio, the Sarah Cannon Blood Cancer Networ, and Texas Oncology, the largest private practice oncology network in the state, Austinites with blood disorders will have access to a state-of-the-art treatment center that will include bone marrow transplant services.

Currently, patients must go to either San Antonio or Houston for these services.

A missing piece

Said Laurence Tokaz, M.D., medical director of St. David's Healthcare Blood Cancer Program:

There are very few things that a resident of Austin who's lived here for 25 to 30 years make them feel like they've got to go down the street to Houston, Dallas, San Antonio or New York. This is a piece of the puzzle that's been missing, and it's significant.

However, the new center will not be without its limits. For instance, it will only be capable of performing autologous stem cell transplants and not allogeniec transplants.

Filling the gap

Said David Huffstutler, president and chief executive officer of St. David’s HealthCare:

We are pleased to fill a critical gap in Austin’s health care infrastructure by bringing this service to the Central Texas region through a collaboration with the Texas Transplant Institute and San Antonio’s Methodist Healthcare.

The first phase of the new blood cancer treatment center opened this past May in the form of new outpatient clinic at St. David’s South Austin Medical Center. The bone marrow transplant center is scheduled to open in early 2014 at the same location.

Source: St. David's

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap